Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer: a single-center cross-sectional analysis

Background/Aim: Cardiotoxicity due to antitumor therapy is a dreaded complication and could thus impact the prognosis of patients with breast cancer. This study sought to analyze the occurrence of adverse cardiovascular events and to identify potential risk factors. Patients and Methods: A total of...

Full description

Saved in:
Bibliographic Details
Main Authors: Rosenkaimer, Stephanie L. (Author) , Sieburg, Tina (Author) , Winter, Laura (Author) , Mavratzas, Athanasios (Author) , Hofmann, Wolf-Karsten (Author) , Hofheinz, Ralf-Dieter (Author) , Akın, Ibrahim (Author) , Dürschmied, Daniel (Author) , Hohneck, Anna (Author)
Format: Article (Journal)
Language:English
Published: May 31, 2022
In: Anticancer research
Year: 2022, Volume: 42, Issue: 6, Pages: 3075-3084
ISSN:1791-7530
DOI:10.21873/anticanres.15795
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21873/anticanres.15795
Verlag, lizenzpflichtig, Volltext: https://ar.iiarjournals.org/content/42/6/3075
Get full text
Author Notes:Stephanie Rosenkaimer, Tina Sieburg, Laura Winter, Athanasios Mavratzas, Wolf-Karsten Hofmann, Ralf-Dieter Hofheinz, Ibrahim Akin, Daniel Duerschmied and Anna Hohneck

MARC

LEADER 00000caa a22000002c 4500
001 1880028581
003 DE-627
005 20240307080035.0
007 cr uuu---uuuuu
008 240206s2022 xx |||||o 00| ||eng c
024 7 |a 10.21873/anticanres.15795  |2 doi 
035 |a (DE-627)1880028581 
035 |a (DE-599)KXP1880028581 
035 |a (OCoLC)1425215346 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rosenkaimer, Stephanie L.  |d 1976-  |e VerfasserIn  |0 (DE-588)1214270085  |0 (DE-627)1725244314  |4 aut 
245 1 0 |a Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer  |b a single-center cross-sectional analysis  |c Stephanie Rosenkaimer, Tina Sieburg, Laura Winter, Athanasios Mavratzas, Wolf-Karsten Hofmann, Ralf-Dieter Hofheinz, Ibrahim Akin, Daniel Duerschmied and Anna Hohneck 
264 1 |c May 31, 2022 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 06.02.2024 
520 |a Background/Aim: Cardiotoxicity due to antitumor therapy is a dreaded complication and could thus impact the prognosis of patients with breast cancer. This study sought to analyze the occurrence of adverse cardiovascular events and to identify potential risk factors. Patients and Methods: A total of 136 patients with breast cancer were divided into two groups based on the occurrence of treatment-related cardiovascular toxicity [event 47 (35%) vs. no event 89 (65%)]. Patients were followed over a median of 45 months (range=37-83 months). Results: Most common events were thromboembolic complications (26%), followed by heart failure (15%) and acute toxic cardiomyopathy (5%), with a reduced left ventricular ejection fraction [LVEF (%), no event 59±5.0 vs. event 55±11, p=0.01 ]. Patients with leftsided breast cancer and an advanced stage disease had a higher risk of developing adverse cardiovascular events. The highest risk was found for patients with a high number of cardiovascular risk factors. In addition to LVEF, mitral annular plane systolic excursion was also significantly reduced in the event group, while there was a trend for higher global longitudinal strain. During follow-up, 26 patients (19.1%) deceased, whereof 12 had a treatment-related cardiovascular event, but without statistical difference. Conclusion: Treatment-related cardiovascular events are relatively common in about one third of patients with breast cancer. Women with a cardiovascular risk profile or an advanced stage disease had a higher risk for adverse events. Despite the treatment-related cardiac deterioration, no difference in mortality was observed during follow up. 
650 4 |a breast cancer 
650 4 |a Cardio-oncology 
650 4 |a global longitudinal strain 
650 4 |a toxic cardiomyopathy 
650 4 |a treatment-related side effects 
700 1 |a Sieburg, Tina  |d 1964-  |e VerfasserIn  |0 (DE-588)1234495317  |0 (DE-627)175932583X  |4 aut 
700 1 |a Winter, Laura  |d 1989-  |e VerfasserIn  |0 (DE-588)1287212700  |0 (DE-627)1843750724  |4 aut 
700 1 |a Mavratzas, Athanasios  |d 1980-  |e VerfasserIn  |0 (DE-588)1048709590  |0 (DE-627)781110890  |0 (DE-576)40302644X  |4 aut 
700 1 |a Hofmann, Wolf-Karsten  |d 1967-  |e VerfasserIn  |0 (DE-588)114154635  |0 (DE-627)691208751  |0 (DE-576)351568336  |4 aut 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
700 1 |a Akın, Ibrahim  |d 1978-  |e VerfasserIn  |0 (DE-588)132322293  |0 (DE-627)521039010  |0 (DE-576)299074366  |4 aut 
700 1 |a Dürschmied, Daniel  |d 1976-  |e VerfasserIn  |0 (DE-588)129152196  |0 (DE-627)390022462  |0 (DE-576)187844623  |4 aut 
700 1 |a Hohneck, Anna  |d 1990-  |e VerfasserIn  |0 (DE-588)1194587674  |0 (DE-627)1676810412  |4 aut 
773 0 8 |i Enthalten in  |t Anticancer research  |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004  |g 42(2022), 6, Seite 3075-3084  |h Online-Ressource  |w (DE-627)387478493  |w (DE-600)2145376-7  |w (DE-576)358408717  |x 1791-7530  |7 nnas  |a Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer a single-center cross-sectional analysis 
773 1 8 |g volume:42  |g year:2022  |g number:6  |g pages:3075-3084  |g extent:10  |a Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer a single-center cross-sectional analysis 
856 4 0 |u https://doi.org/10.21873/anticanres.15795  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ar.iiarjournals.org/content/42/6/3075  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240206 
993 |a Article 
994 |a 2022 
998 |g 1194587674  |a Hohneck, Anna  |m 1194587674:Hohneck, Anna  |d 60000  |d 61000  |e 60000PH1194587674  |e 61000PH1194587674  |k 0/60000/  |k 1/60000/61000/  |p 9  |y j 
998 |g 129152196  |a Dürschmied, Daniel  |m 129152196:Dürschmied, Daniel  |d 60000  |d 61000  |e 60000PD129152196  |e 61000PD129152196  |k 0/60000/  |k 1/60000/61000/  |p 8 
998 |g 132322293  |a Akın, Ibrahim  |m 132322293:Akın, Ibrahim  |d 60000  |d 61000  |e 60000PA132322293  |e 61000PA132322293  |k 0/60000/  |k 1/60000/61000/  |p 7 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 6 
998 |g 114154635  |a Hofmann, Wolf-Karsten  |m 114154635:Hofmann, Wolf-Karsten  |d 60000  |d 61200  |e 60000PH114154635  |e 61200PH114154635  |k 0/60000/  |k 1/60000/61200/  |p 5 
998 |g 1048709590  |a Mavratzas, Athanasios  |m 1048709590:Mavratzas, Athanasios  |d 60000  |d 61300  |e 60000PM1048709590  |e 61300PM1048709590  |k 0/60000/  |k 1/60000/61300/  |p 4 
998 |g 1287212700  |a Winter, Laura  |m 1287212700:Winter, Laura  |d 60000  |d 61000  |d 60000  |d 65000  |e 60000PW1287212700  |e 61000PW1287212700  |e 60000PW1287212700  |e 65000PW1287212700  |k 0/60000/  |k 1/60000/61000/  |k 0/60000/  |k 1/60000/65000/  |p 3 
998 |g 1234495317  |a Sieburg, Tina  |m 1234495317:Sieburg, Tina  |d 60000  |d 61000  |d 60000  |d 65000  |e 60000PS1234495317  |e 61000PS1234495317  |e 60000PS1234495317  |e 65000PS1234495317  |k 0/60000/  |k 1/60000/61000/  |k 0/60000/  |k 1/60000/65000/  |p 2 
999 |a KXP-PPN1880028581  |e 4477374763 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Rosenkaimer","display":"Rosenkaimer, Stephanie L.","given":"Stephanie L.","role":"aut"},{"given":"Tina","role":"aut","display":"Sieburg, Tina","family":"Sieburg"},{"display":"Winter, Laura","family":"Winter","role":"aut","given":"Laura"},{"role":"aut","given":"Athanasios","display":"Mavratzas, Athanasios","family":"Mavratzas"},{"display":"Hofmann, Wolf-Karsten","family":"Hofmann","given":"Wolf-Karsten","role":"aut"},{"family":"Hofheinz","display":"Hofheinz, Ralf-Dieter","given":"Ralf-Dieter","role":"aut"},{"display":"Akın, Ibrahim","family":"Akın","role":"aut","given":"Ibrahim"},{"given":"Daniel","role":"aut","display":"Dürschmied, Daniel","family":"Dürschmied"},{"role":"aut","given":"Anna","family":"Hohneck","display":"Hohneck, Anna"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer","subtitle":"a single-center cross-sectional analysis","title_sort":"Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"May 31, 2022"}],"note":["Gesehen am 06.02.2024"],"id":{"eki":["1880028581"],"doi":["10.21873/anticanres.15795"]},"physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Stephanie Rosenkaimer, Tina Sieburg, Laura Winter, Athanasios Mavratzas, Wolf-Karsten Hofmann, Ralf-Dieter Hofheinz, Ibrahim Akin, Daniel Duerschmied and Anna Hohneck"]},"recId":"1880028581","relHost":[{"part":{"volume":"42","extent":"10","pages":"3075-3084","year":"2022","text":"42(2022), 6, Seite 3075-3084","issue":"6"},"language":["eng"],"disp":"Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer a single-center cross-sectional analysisAnticancer research","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 26.02.13"],"pubHistory":["Nachgewiesen 24.2004 -"],"origin":[{"publisherPlace":"Kapandriti, Attiki, Greece","dateIssuedKey":"2004","publisher":"International Institute of Anticancer Research","dateIssuedDisp":"2004-"}],"title":[{"title_sort":"Anticancer research","subtitle":"international journal of cancer research and treatment","title":"Anticancer research"}],"id":{"eki":["387478493"],"zdb":["2145376-7"],"issn":["1791-7530"]},"name":{"displayForm":["International Institute of Anticancer Research"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"387478493"}]} 
SRT |a ROSENKAIMEADVERSECAR3120